These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22146482)

  • 21. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
    Nazik H; Ongen B; Erturan Z; Salcioğlu M
    Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Etherington C; Hall M; Conway S; Peckham D; Denton M
    J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients.
    Zamorano L; Juan C; Fernández-Olmos A; Ge Y; Cantón R; Oliver A
    Clin Microbiol Infect; 2010 Sep; 16(9):1482-7. PubMed ID: 20002107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.
    Martin LW; Robson CL; Watts AM; Gray AR; Wainwright CE; Bell SC; Ramsay KA; Kidd TJ; Reid DW; Brockway B; Lamont IL
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa.
    Somayaji R; Waddell B; Workentine ML; Surette MG; Brager NP; Rabin HR; Parkins MD
    BMC Pulm Med; 2015 Nov; 15():138. PubMed ID: 26542115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic & genotypic variants of Pseudomonas aeruginosa isolated from children with cystic fibrosis in India.
    Agarwal G; Kapil A; Kabra SK; Chandra R; Das B; Diwedi SN
    Indian J Med Res; 2002 Aug; 116():73-81. PubMed ID: 12592994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic.
    Vosahlikova S; Drevinek P; Cinek O; Pohunek P; Maixnerova M; Urbaskova P; van den Reijden TJ; Dijkshoorn L; Nemec A
    Res Microbiol; 2007 May; 158(4):324-9. PubMed ID: 17448645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain.
    Parkins MD; Glezerson BA; Sibley CD; Sibley KA; Duong J; Purighalla S; Mody CH; Workentine ML; Storey DG; Surette MG; Rabin HR
    J Clin Microbiol; 2014 Apr; 52(4):1127-35. PubMed ID: 24452167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center.
    Lee TW; Brownlee KG; Denton M; Littlewood JM; Conway SP
    Pediatr Pulmonol; 2004 Feb; 37(2):104-10. PubMed ID: 14730654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of susceptibility of cystic-fibrosis-related and non-cystic-fibrosis-related Pseudomonas aeruginosa to chlorine-based disinfecting solutions: implications for infection prevention and ward disinfection.
    Moore JE; Rendall JC
    J Med Microbiol; 2014 Sep; 63(Pt 9):1214-1219. PubMed ID: 24925907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection.
    López-Causapé C; Rojo-Molinero E; Mulet X; Cabot G; Moyà B; Figuerola J; Togores B; Pérez JL; Oliver A
    PLoS One; 2013; 8(8):e71001. PubMed ID: 23951065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-infections with Pseudomonas aeruginosa in patients with cystic fibrosis attending the Warsaw Centre.
    Milczewska J; Wołkowicz T; Zacharczuk K; Kwiatkowska M
    Dev Period Med; 2015; 19(1):60-5. PubMed ID: 26003071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed morphotype susceptibility testing of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Dunne WM; Chusid MJ
    Diagn Microbiol Infect Dis; 1987 Feb; 6(2):165-70. PubMed ID: 3102157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).
    Oermann CM; McCoy KS; Retsch-Bogart GZ; Gibson RL; McKevitt M; Montgomery AB
    J Antimicrob Chemother; 2011 Oct; 66(10):2398-404. PubMed ID: 21784781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PCR-based detection of a cystic fibrosis epidemic strain of Pseudomonas Aeruginosa.
    Panagea S; Winstanley C; Parsons YN; Walshaw MJ; Ledson MJ; Hart CA
    Mol Diagn; 2003; 7(3-4):195-200. PubMed ID: 15068391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
    Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Label-free quantitative proteomics identifies unique proteomes of clinical isolates of the Liverpool Epidemic Strain of Pseudomonas aeruginosa and laboratory strain PAO1.
    Goodyear MC; Garnier N; Krieger JR; Geddes-McAlister J; Khursigara CM
    Proteomics Clin Appl; 2021 Nov; 15(6):e2100062. PubMed ID: 34510773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.
    Ciofu O; Riis B; Pressler T; Poulsen HE; Høiby N
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2276-82. PubMed ID: 15917521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection.
    Darch SE; McNally A; Harrison F; Corander J; Barr HL; Paszkiewicz K; Holden S; Fogarty A; Crusz SA; Diggle SP
    Sci Rep; 2015 Jan; 5():7649. PubMed ID: 25578031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.